USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth
文献类型：期刊论文
| 作者 | An, Tao1,3 ; Gong, Yaxiao1,3; Li, Xue1,3; Kong, Lingmei1,3; Ma, Pengcheng2; Gong, Liang1,3; Zhu, Huifang1,3; Yu, Chunlei1,3; Liu, Jianmei1,3; Zhou, Hongyu1
|
| 刊名 | BIOCHEMICAL PHARMACOLOGY
 |
| 出版日期 | 2017-05-01 |
| 卷号 | 131期号:1页码:29-39 |
| 关键词 | USP7 inhibitor Wnt signaling Colorectal cancer |
| 英文摘要 | Aberrant activation of Wnt/beta-catenin signaling is closely associated with the development of various human cancers, especially colorectal cancers (CRC). The ubiquitin proteasome system (UPS) is essential in the regulation of Wnt signaling and inhibitors targeting the UPS could have great potential in CRC therapy. Ubiquitin-specific protease 7 (USP7), a deubiquitinating enzyme, plays a significant role in neoplastic diseases due to its well-known function of regulating the MDM2-p53 complex. Inspired by our recent study identifying the positive role of USP7 in the Wnt signaling, we report here that USP7 is overexpressed in colorectal carcinoma cell lines and tissues, which is closely related with the poor prognosis. USP7 knockdown inhibits the proliferation of CRC cells with different p53 status, and USP7 inhibition by its inhibitor P5091 attenuates the activity of Wnt signaling via enhanced ubiquitination and the subsequent degradation of beta-catenin. In vitro, P5091 inhibited the proliferation and induced apoptosis of CRC cells. P5091 also suppressed in vivo tumor growth in the HCT116 xenograft mouse model, which is consistently associated with reduced expression of beta-catenin and Wnt target genes. In conclusion, our pre-clinical study indicated that USP7 could be a potential drug target and its inhibitor P5091 deserves further development as anticancer agent for Wnt hyper-activated CRC therapy. (C) 2017 Elsevier Inc. All rights reserved. |
| 类目[WOS] | Pharmacology & Pharmacy |
| 研究领域[WOS] | Pharmacology & Pharmacy |
| 关键词[WOS] | UBIQUITIN-PROTEASOME SYSTEM ; BETA-CATENIN DEGRADATION ; CASEIN KINASE 1-ALPHA ; COLON-CANCER CELLS ; PATHWAY ; PROTEIN ; ROLES ; EXPRESSION ; APOPTOSIS ; TARGETS |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000399256700003 |
| 源URL | [http://ir.kib.ac.cn/handle/151853/33830]  |
| 专题 | 昆明植物研究所_植物化学与西部植物资源持续利用国家重点实验室 |
| 作者单位 | 1.Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Ch, 132 Lanhei Rd, Kunming 650201, Yunnan, Peoples R China 2.Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China 3.Univ Chinese Acad Sci, Beijing, Peoples R China |
| 推荐引用方式 GB/T 7714 | An, Tao,Gong, Yaxiao,Li, Xue,et al. USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth[J]. BIOCHEMICAL PHARMACOLOGY,2017,131(1):29-39. |
| APA | An, Tao.,Gong, Yaxiao.,Li, Xue.,Kong, Lingmei.,Ma, Pengcheng.,...&Li, Yan.(2017).USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth.BIOCHEMICAL PHARMACOLOGY,131(1),29-39. |
| MLA | An, Tao,et al."USP7 inhibitor P5091 inhibits Wnt signaling and colorectal tumor growth".BIOCHEMICAL PHARMACOLOGY 131.1(2017):29-39. |
入库方式： OAI收割
来源：昆明植物研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。